PPI - Radically Pragmatic
  • Donate
Skip to content
  • Home
  • About
    • About Us
    • Locations
    • Careers
  • People
  • Projects
  • Our Work
  • Events
  • Donate

Our Work

The Value of the Medicare Part D Program for its Beneficiaries and the Medicare System

  • December 7, 2016
  • Robert J. Shapiro
Download PDF

In the United States and other advanced countries, governments and individuals regularly lament the high and ever-rising costs of healthcare; and the ongoing aging of their populations virtually ensures that these costs will continue to increase — perhaps at substantial rates.

Many analysts identify the development and broad use of new healthcare technologies as primary sources of these cost increases; and, in the public debate over rising costs, new prescription drugs are often singled out as critical cost drivers. This study examines the cost-benefit calculus for prescription drugs in the context of Medicare and overall healthcare in the United States.

 

Medicare_Part_D

 

Related Work

Blog  |  May 21, 2025

Republicans Surrender the War on Cancer

  • Alix Ware
Blog  |  May 19, 2025

The Media’s Misguided Coverage of Smoke-Free Nicotine Products

  • Lindsay Mark Lewis
Blog  |  December 9, 2024

Why the U.S. Senate Should Reject RFK Jr.

  • Daphne Hansell
Press Release  |  October 21, 2024

New PPI Report Proposes Solutions to Reduce Health Care Costs for Working Americans

  • Erin Delaney
Publication  |  October 21, 2024

A Comprehensive Plan to Lower Health Costs Without Reducing Coverage

  • Erin Delaney
Blog  |  September 12, 2024

Harris’ Pledge: Affordable Health Care and Reproductive Rights

  • Erin Delaney
  • Never miss an update:

  • Subscribe to our newsletter
PPI Logo
  • Twitter
  • LinkedIn
  • Facebook
  • Donate
  • Careers
  • © 2025 Progressive Policy Institute. All Rights Reserved.
  • |
  • Privacy Policy
  • |
  • Privacy Settings